<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药通社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-10T23:40:10+08:00</updated>
  <subtitle>医药：政策、资讯、产业、发展</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>我国创新药专利期限补偿计算方式探讨</title>
    <updated>2021-01-10T21:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/LXIyoSEcAF3oQJ-2-x3sig</id>
    <link href="https://mp.weixin.qq.com/s/LXIyoSEcAF3oQJ-2-x3sig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA公开征求《牙膏备案资料规范》意见</title>
    <updated>2021-01-10T21:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/QJZtCZXKR-n4R8QW53OKLw</id>
    <link href="https://mp.weixin.qq.com/s/QJZtCZXKR-n4R8QW53OKLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【产业观察】以为小适应症，结果TRK新药大热门</title>
    <updated>2021-01-10T21:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/KuruDDmoOoNLKIm0rZv5Vg</id>
    <link href="https://mp.weixin.qq.com/s/KuruDDmoOoNLKIm0rZv5Vg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-10T21:44:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-10:/s/cJpJ6YH6PH2CJrymyRTPJQ</id>
    <link href="https://mp.weixin.qq.com/s/cJpJ6YH6PH2CJrymyRTPJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>齐鲁制药：共计49个产品通过一致性评价</title>
    <updated>2021-01-09T21:54:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/ccsXSKfGgWto_S5m4Y7z3Q</id>
    <link href="https://mp.weixin.qq.com/s/ccsXSKfGgWto_S5m4Y7z3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>宜昌人福药业：累计15个品种通过一致性评价</title>
    <updated>2021-01-09T21:54:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/jcnu-OA19pUd_0SjaybhVg</id>
    <link href="https://mp.weixin.qq.com/s/jcnu-OA19pUd_0SjaybhVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗全民免费接种！医保基金和财政共同负担</title>
    <updated>2021-01-09T21:54:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/VW334WH5eocvrImhdEhOoQ</id>
    <link href="https://mp.weixin.qq.com/s/VW334WH5eocvrImhdEhOoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-09T21:54:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-09:/s/87K_8Xi80jiIUmXl8VvIeQ</id>
    <link href="https://mp.weixin.qq.com/s/87K_8Xi80jiIUmXl8VvIeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE《化学药品注射剂灭菌和无菌工艺研究及验证指导原则（试行）》</title>
    <updated>2021-01-08T19:49:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/BCSun3xh3r9fyaMmR2oEvQ</id>
    <link href="https://mp.weixin.qq.com/s/BCSun3xh3r9fyaMmR2oEvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DOE试验设计在湿法制粒工艺优化中的应用</title>
    <updated>2021-01-08T19:49:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/IQihfmyxZsX8PYoYi0eGTA</id>
    <link href="https://mp.weixin.qq.com/s/IQihfmyxZsX8PYoYi0eGTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-08T19:49:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/lh9YAD1X0l2PtKu8OTw2ug</id>
    <link href="https://mp.weixin.qq.com/s/lh9YAD1X0l2PtKu8OTw2ug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>6000亿恒瑞，全球研发总部项目在张江开工</title>
    <updated>2021-01-07T09:09:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/5dt9EvZ-mbspSUTwLCBSXw</id>
    <link href="https://mp.weixin.qq.com/s/5dt9EvZ-mbspSUTwLCBSXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA发文：一大批注射剂通过一致性评价！6药企、7产品、18品规！</title>
    <updated>2021-01-07T09:09:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/6_sNIEh-tT66wripC4gYkQ</id>
    <link href="https://mp.weixin.qq.com/s/6_sNIEh-tT66wripC4gYkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-07T09:09:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/A24xmU13mNNIVdCLdl66Zw</id>
    <link href="https://mp.weixin.qq.com/s/A24xmU13mNNIVdCLdl66Zw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>干货汇总 ▏药剂学之液体制剂相关知识</title>
    <updated>2021-01-06T22:58:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/eHUrZG1ealtHCF5BP1iocg</id>
    <link href="https://mp.weixin.qq.com/s/eHUrZG1ealtHCF5BP1iocg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有增补、有未通过、第38批参比制剂公布！</title>
    <updated>2021-01-06T22:58:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/otEwIzDugKhUCfp39D8t2A</id>
    <link href="https://mp.weixin.qq.com/s/otEwIzDugKhUCfp39D8t2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2021-01-06T22:58:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/6bXrVLSlbEow6hLaT8JWGQ</id>
    <link href="https://mp.weixin.qq.com/s/6bXrVLSlbEow6hLaT8JWGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>112个批文！NMPA2021年01月05日药品批准证明文件待领取信息发布</title>
    <updated>2021-01-05T18:17:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/OF0FoMuuNXM4VOPHyZXmQg</id>
    <link href="https://mp.weixin.qq.com/s/OF0FoMuuNXM4VOPHyZXmQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>维健医药与Immedica签署协议，维健医药获得Ravicti®在中国和其他若干亚太国家的独家商业化权益</title>
    <updated>2021-01-05T18:17:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/2_I8pIUe_xZdWCL7l5vjcg</id>
    <link href="https://mp.weixin.qq.com/s/2_I8pIUe_xZdWCL7l5vjcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>石药欧意：达沙替尼片新4类获批，首家过评！</title>
    <updated>2021-01-05T18:17:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/susDalM3sc2Aztz5IbDH6g</id>
    <link href="https://mp.weixin.qq.com/s/susDalM3sc2Aztz5IbDH6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>